
Cure Stream builds an autonomous artificial pancreas system that automates hormone injection decisions to simplify glucose management for people with diabetes. The system uses AI-driven hormone injection decision algorithms to operate as a closed-loop medical device, performing continuous monitoring and automated dosing decisions. It is a medical-device-focused B2C offering with potential B2B channels through healthcare providers and clinical partners. Core technologies include AI decision models and autonomous control algorithms for hormone delivery. The company targets the diabetes management market with a product designed for continuous, automated glycemic control.

Cure Stream builds an autonomous artificial pancreas system that automates hormone injection decisions to simplify glucose management for people with diabetes. The system uses AI-driven hormone injection decision algorithms to operate as a closed-loop medical device, performing continuous monitoring and automated dosing decisions. It is a medical-device-focused B2C offering with potential B2B channels through healthcare providers and clinical partners. Core technologies include AI decision models and autonomous control algorithms for hormone delivery. The company targets the diabetes management market with a product designed for continuous, automated glycemic control.